Masanja M I, Kalyanyama B M, Simon E N M
Faculty of Dentistry, Muhimbili University College of Health Sciences, P.O. Box 65014, Dar es Salaam, Tanzania.
East Afr Med J. 2003 Aug;80(8):429-34. doi: 10.4314/eamj.v80i8.8736.
To determine the pattern of occurrence of salivary gland tumours in Tanzania over a period of twenty years.
Cross-sectional retrospective study.
Two referral centres; Muhimbili National Hospital (MNH) and Kilimanjaro Christian Medical Centre (KCMC).
Medical records of patients who presented with tumours of the salivary glands in the two major referral centres over a period of twenty years from 1982 to 2001 were reviewed. Data regarding demographic, clinical and histologic information was analysed.
Salivary gland tumours constituted 6.3% of all oral-facial tumours and tumour like lesions. Among the salivary gland tumours, 54% were benign and 46% malignant, which occurred in 80 males and 53 females. Peak age was between 20 and 49 years, with a male-female ratio of 1.5:1 (p<0.05). Pleomorphic adenoma was the commonest occurring tumour (44.4%) followed by adenoid cystic carcinoma (24.8%), mucoepidermoid carcinoma (9.8%) and adenocarcinoma (6.5%). Among the benign tumours, pleomorphic adenoma dominated (83.9%), followed by adenoma (9.9%). Among malignant tumours adenoid cystic carcinoma occurred in 54.3% followed by mucoepidemoid carcinoma (22.9%) and adenocarcinoma (11.4%). The parotid gland was the commonest site of occurrence followed by the palate. At initial stages the only complaint from the patients was essentially a slowly growing painless swelling. Treatment modality was mainly surgical in both benign and malignant tumours, however, for malignant tumours radiotherapy alone or in combination with surgery was sometimes employed.
On average salivary gland tumours occurred at a relatively younger age compared to that reported in Western countries. Contrary to reports from Europe and America, adenoid cystic carcinoma was the most frequently occurring malignant salivary gland tumour. Late presentation was seen as a problem that needs to be addressed in order to maximise the effectiveness of treatment.
确定坦桑尼亚20年间涎腺肿瘤的发病模式。
横断面回顾性研究。
两个转诊中心;穆希姆比利国家医院(MNH)和乞力马扎罗基督教医疗中心(KCMC)。
回顾了1982年至2001年20年间在这两个主要转诊中心就诊的涎腺肿瘤患者的病历。分析了有关人口统计学、临床和组织学信息的数据。
涎腺肿瘤占所有口腔面部肿瘤和肿瘤样病变的6.3%。在涎腺肿瘤中,54%为良性,46%为恶性,发生于80名男性和53名女性。发病高峰年龄在20至49岁之间,男女比例为1.5:1(p<0.05)。多形性腺瘤是最常见的肿瘤(44.4%),其次是腺样囊性癌(24.8%)、黏液表皮样癌(9.8%)和腺癌(6.5%)。在良性肿瘤中,多形性腺瘤占主导(83.9%),其次是腺瘤(9.9%)。在恶性肿瘤中,腺样囊性癌占54.3%,其次是黏液表皮样癌(22.9%)和腺癌(11.4%)。腮腺是最常见的发病部位,其次是腭部。在疾病初期,患者唯一的主诉基本上是缓慢生长的无痛性肿胀。良性和恶性肿瘤的治疗方式主要都是手术,然而,对于恶性肿瘤,有时单独采用放疗或放疗联合手术。
与西方国家的报道相比,涎腺肿瘤平均发病年龄相对较小。与欧美报道相反,腺样囊性癌是最常见的恶性涎腺肿瘤。就诊延迟被视为一个需要解决的问题,以便最大限度地提高治疗效果。